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tation of economic evidence. Presenting methods and results in
a transparent manner is a key principle of the Guidelines. CON-
CLUSIONS: The CCOHTA Guidelines for conducting economic
evaluations has been updated. The extent to which those doing
economic evaluations follow the Guidelines, and the degree to
which decision-makers actually use the resulting economic evi-
dence for decision-making, will reﬂect the value of the new
Guidelines.
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OBJECTIVES: To measure the impact different prescription
market basket deﬁnitions have on coverage and inﬂation.
METHODS: January 2001 through December 2002 claims were
extracted for 15 groups. The number of claims, percentage of
the market basket missing (coverage), and inﬂation (using
Laspeyres) were calculated. Days supply and quantity dispensed
were aggregated into different prescription drug market baskets
using each drug’s full NDC, a unique combination of active
ingredient, strength, form, brand/generic, and multi/single
source, brand name and generic name for different units of time
including: monthly, quarterly, semi-annually, and yearly. Inﬂa-
tion was calculated with and without compounds and copaxone.
RESULTS: The number of claims per group ranged from
263,318 to 17,455,237 (with 6 below, 6 above and 3 between 1
to 2 million). Aggregating by NDCs led to the largest gaps in
market basket coverage with between 13% and 38% of NDCs
without a match in a corresponding time periods. The other
methods had gaps in coverage ranging from about 8% to 32%.
Monthly intervals generally had 2 to 3 times the number of
missing days supply (range: 0.05% to 11.1%) or quantity (range:
0.2% to 4.8%) than other time intervals (day supply range:
0.2% to 5.0%, quantity range: 0.1% to 3.0%). Inﬂation ranged
from 6.5% to 15.5% with generally higher values for the deﬁn-
itions using name. CONCLUSIONS: Careful attention should be
paid to how prescription drug market baskets are deﬁned when
comparing or calculating inﬂation. Deﬁning prescriptions drugs
at the lowest possible level, particularly for small populations,
can create systematic gaps in the market basket. Deﬁning the
market basket too broadly can create price variations. Both may
reﬂect quality change bias as well as substitution biases in the
prescription drug market basket.
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OBJECTIVE: To analyze patient and family satisfaction with the
education provided to them during hospitalization. METHODS:
Six quarters of data for the year 2002–2003 obtained from Press-
Ganey surveys based on a Likert Scale with scores of 1 and 5
representing very poor and very good results respectively are
analyzed. Patient Satisfaction (PS) scores with 1) explanation
during tests and treatment, and 2) informing family regarding
condition and treatment are cross tabulated using SPSS with spe-
cialty area and Diagnostic Related Group (DRG) product line.
RESULTS: For the group of explanation during tests and treat-
ments—very good scores are reported from the specialty of areas
of Neonatology (75%), Intensive Care (69%), Neurology (61%)
and Labor and Delivery (57%) while the specialties of Psychia-
try (25%) and Skilled Nursing (35%) have lower proportion of
these scores. The DRG product lines of cardiac catheterization
(65%), dentistry (71%), Neonatology (68%), open heart surgery
(56%) have very good scores while HIV (0%), Psychiatry and
Drug Abuse (32%), Otolaryngology (35%) and Opthalmology
(36%) have lower proportion of these scores. Explanation
during tests and treatment and informing family regarding con-
dition and treatment are signiﬁcantly correlated (p < .01, r =
.544) and the scores are almost similar for the second group. The
overall combined percentage with scores of 4 and 5 on the survey
is 88 percent. CONCLUSION: More effort should be should be
made to convert the scores of 4’s to 5’s. The satisfaction scores
for the specialties of Psychiatry, Skilled Nursing and the DRG of
HIV are areas of concern. Maybe it is the inherent nature of the
conditions encountered in these areas that prevent patients from
having a good understanding of the explanations. Patient edu-
cation and patient satisfaction are closely interlinked and edu-
cating patients does enhance satisfaction scores.
PHP29
CONSUMER SATISFACTION WITH HEALTH PLANS AND
DRUG BENEFIT MANAGEMENT STRATEGIES
Sansgiry SS, Sikri S, Kawatkar A
University of Houston, Houston,TX, USA
OBJECTIVES: Managed care has implemented various drug
beneﬁts management strategies like formularies, that most
patients lack understanding of and may lead to dissatisfaction.
The objective of this study was to evaluate consumer satisfaction
with health plans and understand their attitude towards drug
beneﬁt management strategies, particularly the use of drug for-
mularies. METHODS: A cross-sectional study was conducted by
administering a survey to consumers (N = 714) waiting to pick
a prescription in community pharmacies (N = 72) in the Houston
metropolitan area. A prevalidated questionnaire was used to
measure satisfaction with health plan using an eleven-item, ﬁve-
point scale where 1-very dissatisﬁed -5 = very satisﬁed. A 12
item strongly disagree (1)—strongly agree (5) Likert scale was
used to measure consumer perceptions and knowledge regarding
drug formularies. Data along with demographic information
such as age, gender, marital status, race, education and income
were collected, coded, and analyzed at a set priori signiﬁcance
level of 0.05 to perform descriptive and correlation analyses.
RESULTS: Among the surveyed population, only 25% of
patients owned a copy of the formulary. Majority of the respon-
dents were white (43%), female (52%), married (52 %), and
working fulltime (64 %) with a mean age of 39.58 (SD 13.96)
years. Overall, consumers had negative attitude towards formu-
laries 2.77 (SD 0.66). Respondents indicated neutral rating with
respect to satisfaction with drugs included on their formulary 3.0
(SD 0.9). Consumers were somewhat satisﬁed with their health
plans 3.51 (SD 0.73). There was a signiﬁcant (p < 0.05) positive
correlation between satisfaction with health plans and attitude
towards formularies (r = 0.176) as well as with satisfaction with
drug coverage (r = 0.369). CONCLUSIONS: Consumers had
negative attitude toward formularies, which may be attributed
to their lack of knowledge regarding formularies. Patient educa-
tion efforts by health plan providers may help change consumer
attitudes and improve satisfaction.
PHP30
PATIENT SATISFACTION WITH HEALTH CARE SERVICES:
IDENTIFYING VOIDS
Sansgiry SS, Jayawant SS, Bhosle MJ
University of Houston, Houston,TX, USA
